Screener

Eligibility screening

Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Sponsored by National Heart, Lung, and Blood Institute (NHLBI)Study detailsClinicalTrials.gov

1 US site in MD

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.